1920 found
|
INN ▲
|
ATC Code ▲
|
Country ▲
|
Classification ▲
|
Last update ▲
|
MA Number ▲
|
Registration date ▲
|
Status ▲
|
|
VANDETANIB |
L01EX04 |
FR
|
I
|
|
|
|
VALID
|
|
REGORAFENIB |
L01EX05 |
FR
|
I
|
|
|
|
VALID
|
|
CABOZANTINIB |
L01EX07 |
FR
|
I
|
07-11-2016 |
EMEA/H/C/002640 |
21-03-2014 |
VALID
|
|
LENVATINIB |
L01EX08 |
FR
|
I
|
07-04-2016 |
EMEA/H/C/003727 |
28-05-2015 |
VALID
|
|
NINTEDANIB |
L01EX09 |
FR
|
I
|
|
|
|
VALID
|
|
MIDOSTAURIN |
L01EX10 |
FR
|
I
|
29-01-2018 |
EMEA/H/C/004095 |
18-09-2017 |
VALID
|
|
QUIZARTINIB |
L01EX11 |
FR
|
I
|
14-05-2024 |
EMEA/H/C/005910 |
06-11-2023 |
VALID
|
|
GILTERITINIB |
L01EX13 |
FR
|
I
|
22-04-2020 |
EMEA/H/C/004752 |
24-10-2019 |
VALID
|
|
CAPMATINIB |
L01EX17 |
FR
|
I
|
27-02-2023 |
EMEA/H/C/004845 |
20-06-2022 |
VALID
|
|
AVAPRITINIB |
L01EX18 |
FR
|
I
|
03-03-2021 |
EMEA/H/C/005208 |
24-09-2020 |
VALID
|
|
RIPRETINIB |
L01EX19 |
FR
|
I
|
25-04-2022 |
EMEA/H/C/005614 |
18-11-2021 |
VALID
|
|
SELPERCATINIB |
L01EX22 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/005375 |
11-02-2021 |
VALID
|
|
PRALSETINIB |
L01EX23 |
FR
|
I
|
25-04-2022 |
EMEA/H/C/005413 |
18-11-2021 |
VALID
|
|
CAPIVASERTIB |
L01EX27 |
FR
|
I
|
29-10-2024 |
EMEA/H/C/006017 |
17-06-2024 |
VALID
|
|
REPOTRECTINIB |
L01EX28 |
FR
|
I
|
02-05-2025 |
EMEA/H/C/006005 |
13-01-2025 |
VALID
|
|
RITUXIMAB |
L01FA01 |
FR
|
I
|
|
|
|
VALID
|
|
OBINUTUZUMAB |
L01FA03 |
FR
|
I
|
|
|
|
VALID
|
|
INOTUZUMAB OZOGAMICIN |
L01FB01 |
FR
|
I
|
29-01-2018 |
EMEA/H/C/004119 |
29-06-2017 |
VALID
|
|
MOXETUMOMAB PASUDOTOX |
L01FB02 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/005322 |
08-02-2021 |
VALID
|
|
DARATUMUMAB |
L01FC01 |
FR
|
I
|
07-11-2016 |
EMEA/H/C/004077 |
20-05-2016 |
VALID
|
|
ISATUXIMAB |
L01FC02 |
FR
|
I
|
03-03-2021 |
EMEA/H/C/004977 |
30-05-2020 |
VALID
|
|
TRASTUZUMAB |
L01FD01 |
FR
|
I
|
|
|
|
VALID
|
|
PERTUZUMAB |
L01FD02 |
FR
|
I
|
|
|
|
VALID
|
|
TRASTUZUMAB EMTANSINE |
L01FD03 |
FR
|
I
|
27-01-2022 |
|
|
VALID
|
|
TRASTUZUMAB DERUXTECAN |
L01FD04 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/005124 |
18-01-2021 |
VALID
|
|
PANITUMUMAB |
L01FE02 |
FR
|
I
|
|
|
|
VALID
|
|
NECITUMUMAB |
L01FE03 |
FR
|
Not authorised
|
27-01-2022 |
|
|
VALID
|
|
NIVOLUMAB |
L01FF01 |
FR
|
I
|
07-04-2016 |
EMEA/H/C/003985 |
19-06-2015 |
VALID
|
|
PEMBROLIZUMAB |
L01FF02 |
FR
|
I
|
07-04-2016 |
EMEA/H/C/003820 |
17-07-2015 |
VALID
|
|
DURVALUMAB |
L01FF03 |
FR
|
I
|
12-11-2018 |
EMEA/H/C/004771 |
20-09-2018 |
VALID
|
|
AVELUMAB |
L01FF04 |
FR
|
I
|
|
EMEA/H/C/004338 |
18-09-2017 |
VALID
|
|
ATEZOLIZUMAB |
L01FF05 |
FR
|
I
|
|
EMEA/H/C/004143 |
21-09-2017 |
VALID
|
|
CEMIPLIMAB |
L01FF06 |
FR
|
I
|
|
EMEA/H/C/004844 |
27-06-2019 |
VALID
|
|
DOSTARLIMAB |
L01FF07 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/005204 |
21-04-2021 |
VALID
|
|
TISLELIZUMAB |
L01FF09 |
FR
|
I
|
14-11-2023 |
EMEA/H/C/005919 |
15-09-2023 |
VALID
|
|
RETIFANLIMAB |
L01FF10 |
FR
|
I
|
29-10-2024 |
EMEA/H/C/006194 |
19-04-2024 |
VALID
|
|
SERPLULIMAB |
L01FF12 |
FR
|
I
|
02-05-2025 |
EMEA/H/C/006170 |
03-02-2025 |
VALID
|
|
TORIPALIMAB |
L01FF13 |
FR
|
I
|
29-10-2024 |
EMEA/H/C/006120 |
19-09-2024 |
VALID
|
|
RAMUCIRUMAB |
L01FG02 |
FR
|
I
|
|
|
|
VALID
|
|
GEMTUZUMAB OZOGAMICIN |
L01FX02 |
FR
|
I
|
12-11-2018 |
EMEA/H/C/004204 |
21-09-2018 |
VALID
|
|
CATUMAXOMAB |
L01FX03 |
FR
|
I
|
02-05-2025 |
EMEA/H/C/005697 |
10-02-2025 |
VALID
|
|
IPILIMUMAB |
L01FX04 |
FR
|
I
|
|
|
|
VALID
|
|
BRENTUXIMAB VEDOTIN |
L01FX05 |
FR
|
I
|
|
|
|
VALID
|
|
DINUTUXIMAB BETA |
L01FX06 |
FR
|
I
|
|
EMEA/H/C/003918 |
08-05-2017 |
VALID
|
|
BLINATUMOMAB |
L01FX07 |
FR
|
I
|
|
EMEA/H/C/003731 |
23-11-2015 |
VALID
|
|
ELOTUZUMAB |
L01FX08 |
FR
|
I
|
07-11-2016 |
EMEA/H/C/003967 |
11-05-2016 |
VALID
|
|
MOGAMULIZUMAB |
L01FX09 |
FR
|
I
|
21-10-2019 |
EMEA/H/C/004232 |
22-11-2018 |
VALID
|
|
OLARATUMAB |
L01FX10 |
FR
|
Not authorised
|
27-01-2022 |
|
|
VALID
|
|
TAFASITAMAB |
L01FX12 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/005436 |
26-08-2021 |
VALID
|
|
ENFORTUMAB VEDOTIN |
L01FX13 |
FR
|
I
|
27-02-2023 |
EMEA/H/C/005392 |
13-04-2022 |
VALID
|
